Back
DiaMedica Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
DMAC
DiaMedica Therapeutics, Inc.
Last Price:
$8.42
Seasonality Move:
9.66%
7 Day Trial
ALL ACCESS PASS
$
7
DiaMedica Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, DiaMedica Therapeutics, Inc. has on average historically risen by 21.5% based on the past 14 years of stock performance.
-
DiaMedica Therapeutics, Inc. has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is DiaMedica Therapeutics, Inc. Stock Undervalued?The current DiaMedica Therapeutics, Inc. [DMAC] share price is $8.42. The Score for DMAC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
DMAC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will DiaMedica Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, DiaMedica Therapeutics, Inc. has on average historically risen by 21.5% based on the past 14 years of stock performance.
DiaMedica Therapeutics, Inc. Stock Rating
Buy
56
DiaMedica Therapeutics, Inc. (DMAC)
is a Buy
Is DiaMedica Therapeutics, Inc. overpriced?
-
DiaMedica Therapeutics, Inc. has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
DiaMedica Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
diamedica.com
52-Week Data
52-Week High:
10.42
52-Week Low:
3.19
Prediction Charts
Market Cap:
438.5M
Price in USD:
8.42
Volume:
180.6K
Beta:
1.21
Technical Analysis
SMA50:
8.39
SMA100:
7.74
SMA200:
6.29
52-Wk Change:
27.38%
Stock Predictions
-
Is DiaMedica Therapeutics, Inc. stock public?Yes, DiaMedica Therapeutics, Inc. is a publicly traded company.
-
What is the DiaMedica Therapeutics, Inc. stock quote today?The DiaMedica Therapeutics, Inc. stock price is 8.42 USD today.
-
How to buy DiaMedica Therapeutics, Inc. stock online?You can buy DiaMedica Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-2 | 8.04 | 8.18 | 8.38 | 7.95 |
| Feb-3 | 8.19 | 8.40 | 8.60 | 7.97 |
| Feb-4 | 8.48 | 7.90 | 8.77 | 7.80 |
| Feb-5 | 7.85 | 7.54 | 7.99 | 7.47 |
| Feb-6 | 7.74 | 8.14 | 8.24 | 7.58 |
| Feb-9 | 8.16 | 8.14 | 8.25 | 7.74 |
| Feb-10 | 8.15 | 8.36 | 8.78 | 8.04 |
| Feb-11 | 8.38 | 8.30 | 8.38 | 8.00 |
| Feb-12 | 8.42 | 8.63 | 8.67 | 8.24 |
| Feb-13 | 8.64 | 8.53 | 9.04 | 8.48 |
| Feb-17 | 8.57 | 8.70 | 8.98 | 8.49 |
| Feb-18 | 8.82 | 8.62 | 8.84 | 8.45 |
| Feb-19 | 8.42 | 8.50 | 8.65 | 8.34 |
| Feb-20 | 8.39 | 8.42 | 8.49 | 8.10 |
DiaMedica Therapeutics, Inc. Earnings
DiaMedica Therapeutics, Inc. Earnings Report: Per Share DiaMedica Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
DiaMedica Therapeutics, Inc. Forecast Revenue Growth
DiaMedica Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for DiaMedica Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.12 per share.
* DiaMedica Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.